Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples